ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

ANP32 Family as Diagnostic, Prognostic, and Therapeutic Biomarker Related to Immune Infiltrates in Hepatocellular Carcinoma

Liu, Xuxu; He, Yuanhang; Wang, Pengfei; Hu, Jie; Hao, Chenjun; Wang, Qiang; Yang, Yang; Sun, Yuanyuan; Ma, Biao; Sun, Hezheng; Xue, Dongbo*; Meng, Xianzhi*哈尔滨医科大学; 1
DISEASE MARKERS2022-3-3DOI: 10.1155/2022/5791471
1被引4阅读
引用收藏
分享

摘要

Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide, with high incidence and mortality rate. There is an urgent need to identify effective diagnostic and prognostic biomarkers for HCC. Members of the acidic leucine-rich nucleophosphoprotein 32 (ANP32) family, which mainly includes ANP32A, ANP32B, and ANP32E, are abnormally expressed and have prognostic value in certain cancers. However, the diagnostic, prognostic, and therapeutic value of ANP32 family members in HCC has not yet been fully studied. In this study, we identified the diagnostic and prognostic value of ANP32 family members in HCC. Transcriptome data from public databases, such as the Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases, suggested that ANP32A, ANP32B, and ANP32E were upregulated in HCC tissues, and high expression of ANP32 family members was associated with advanced pathologic stage and histologic grade. Our immunohistochemistry and western blot results further verified the differential expression of ANP32 family members. ANP32A, ANP32B, and ANP32E had an outstanding diagnostic potential. Survival analysis of HCC patients in TCGA databases demonstrated that ANP32A, ANP32B, and ANP32E were associated with poor overall survival (OS) and disease-specific survival (DSS). Univariate and multivariate Cox analyses suggested the capability of ANP32B and ANP32E to independently predict the OS and DSS of HCC patients. Gene set enrichment analysis (GSEA) showed that ANP32 family members were associated with immune response, epidermal cell differentiation, and stem cell proliferation. Expression of ANP32 family members was associated with immune cell infiltration and immune status in the tumor microenvironment of HCC, and patients with high ANP32 family expression had poor sensitivity to immunotherapy. Finally, we identified potential chemotherapy drugs for HCC patients with high ANP32 family expression by CellMiner database. This study suggested the diagnostic, prognostic, and therapeutic roles of the ANP32 family in HCC patients, providing potential therapeutic targets for HCC.

学科与关键词

关键词
PROMOTES
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
DISEASE MARKERS
发表日期
2022-03-03
卷期
第 2022 卷
页码
5791471
DOI
10.1155/2022/5791471
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Sciences Foundation of China [81770634, 81602337]; Education Department of Heilongjiang Province [UNPYSCT-2017062, 12541305]

作者

  • L

    Liu, Xuxu (第一作者)

    1 · harbin med univ

  • H

    He, Yuanhang

    1 · harbin med univ

查看全部 12 位作者收起作者
  • W

    Wang, Pengfei

    1 · harbin med univ

  • H

    Hu, Jie

    1 · harbin med univ

  • H

    Hao, Chenjun

    1 · harbin med univ

  • W

    Wang, Qiang

    1 · harbin med univ

  • Y

    Yang, Yang

    1 · harbin med univ

  • S

    Sun, Yuanyuan

    1 · harbin med univ

  • M

    Ma, Biao

    1 · harbin med univ

  • S

    Sun, Hezheng

    1 · harbin med univ

  • X

    Xue, Dongbo (通讯)

    1 · harbin med univ

  • M

    Meng, Xianzhi (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417